Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.

Publication Type:

Journal Article


The Prostate, Volume 68, Issue 3, p.281-6 (2008)


2008, Aged, Biopsy, Enzyme Inhibitors, Finasteride, Humans, Linear Models, Male, Middle Aged, Prostatic Neoplasms, Public Health Sciences Division, Treatment Outcome, Weight Gain


Finasteride affects both prostate cancer risk and body weight. We examined whether, during 7 years of finasteride treatment, the magnitude of weight change was associated with the diagnosis of no, low-, or high-grade cancer.